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Background. The association between low socioeconomic status and poor physical functioning has been well
described; biomedical factors may play an important role in explaining these differences. This study examines the
association between socioeconomic status and incident mobility limitation in well-functioning older adults, and seeks to
determine whether this link could be explained by biomedical factors.
Methods. Data were obtained from 3066 men and women, aged 70–79 years from Pittsburgh, Pennsylvania and
Memphis, Tennessee participating in the Health, Aging and Body Composition (Health ABC) study. Three indicators of
socioeconomic status were used: education, income, and ownership of financial assets. Mobility limitation was defined as
reporting difficulty walking 1/4 mile or climbing 10 steps during two consecutive semiannual assessments over 4.5 years.
Biomedical factors included a wide range of diseases (e.g., heart and cerebrovascular disease) and biological risk factors
(e.g. hypertension, poor pulmonary function, and high serum levels of inflammatory markers).
Results. Adjusted hazard ratios of incident mobility limitation were significantly higher in those persons with low
education, low income, and few assets. Hazard ratios ranged from 1.66 to 2.80 in the lowest socioeconomic groups.
Additional adjustment for biomedical factors reduced the hazard ratios by an average of 41% for education, 17% for
income, and 29% for assets.
Conclusion. Biomedical factors can account for some of the association between socioeconomic status and incident
mobility limitation. However, to reduce physical disabilities and, in particular, the socioeconomic differences therein, it
may not be sufficient to solely intervene upon biological risk factors and risks of diseases.
THE association between low socioeconomic status(SES) and poor physical functioning has been well
described (1–4), and several authors hypothesize that
biomedical factors such as diseases and biological risk
factors play an important role in explaining these differences
(5–7). Low SES is a risk factor for cardiovascular disease
and stroke, as well as a variety of other diseases (8–10).
Obesity, high blood pressure, glucose intolerance, and
reduced lung function are also more prevalent among low
SES groups in comparison with high SES groups (11–14).
Several of these biomedical factors have been directly
related to adverse functional outcomes (4,15,16). As
important as disease and established disease risk factors
may be in predicting function, data are emerging to suggest
that certain inflammatory markers also play an important
role, independent of prevalent clinical disease (17–20). Two
recent studies (21,22) also show that persons with low SES
have higher serum levels of inflammatory markers than do
persons with high SES.
Despite the knowledge that low SES is related to both
poorer function and increased prevalence of many diseases
and their risk factors, the extent to which biomedical factors
can explain the relationship between low SES and functional
decline has not been studied extensively. Knowledge of
possible biological pathways underlying the association
between SES and poor functional outcomes may give
insight into potential ways of reducing SES differentials in
physical functioning.
In the present study, we examine the association between
SES and incident persistent mobility limitation in a large
community-based cohort of well-functioning older adults,
and seek to determine whether this link can be explained by
biomedical factors.
METHODS
Study Population
The Health, Aging and Body Composition (Health ABC)
study is a longitudinal cohort study consisting of 3075
well-functioning, 70- to 79-year-old, black and white men
and women. Participants were identified from a random
sample of white Medicare beneficiaries and all age-eligible
community-dwelling black residents in designated ZIP code
areas surrounding Memphis, Tennessee, and Pittsburgh,
Pennsylvania. Participants were eligible if they reported
themselves to be well-functioning and free of difficulty with
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any activity of daily living. ‘Well-functioning’ was defined
as having no difficulty in either walking 1/4 mile or going
up 10 steps without resting. Participants were excluded if
they reported a history of active treatment for cancer in the
prior 3 years, planned to move out of the study area within
the next 3 years, or were currently participating in
a randomized trial of a life-style intervention. Baseline data,
collected between April 1997 and June 1998, included an
in-person interview and a clinic-based examination, with
evaluation of body composition, clinical and subclinical
diseases, and physical functioning. Four and a half years of
follow-up were used in this study. For nine participants,
outcome data or SES data were missing, leaving 3066
participants for the present analyses. All participants signed
informed written consent approved by the institutional
review boards of the clinical sites.
Measures
SES.—Three indicators of SES were used: education, family
income, and ownership of financial assets. Categories for
education were: less than 12 years, 12 years, and more than 12
years. Family income was measured by adding all reported
income components of all household members. Income was
defined as any source of income including: wages, salaries,
social security or retirement benefits, help from relatives, and
rent from property. Four categories of family income were
distinguished: less than $10,000, between $10,000 and less
than $25,000, between $25,000 and less than $50,000, and
greater than or equal to $50,000. Because of the large number of
participants with missing income data, a fifth category was
created for this group. Financial assets included: money market
account, saving bonds or treasury bills, home ownership or
investment property or housing, a business or farm, stock or
stock mutual funds, an individual retirement account (IRA) or
KEOGH account, and other investments. Three categories were
created: none, one or two, and three to seven (23). Rather than
use a dichotomous variable of any versus no assets, categories
were used because the literature has shown that various SES
gradients have significant effect on health outcomes (24).
Incident persistent mobility limitation.—The occurrence
of mobility limitation over 4½ years of follow-up was
determined every 6 months, at study assessment visits (12,
24, 36, and 48 months after baseline), or during telephone
follow-up assessments (6, 18, 30, 42, and 54 months after
baseline). Incident persistent mobility limitation was
considered to be present when a person reported any
difficulty walking one quarter mile or climbing 10 steps at
two semiannual follow-up assessments. The requirement
that mobility limitation needed to be present at two
consecutive assessments selected participants with more
chronic and severe functional limitation; therefore, this
outcome was thought to be a more reliable indicator of
a clinically relevant change in functional status. The
incidence of mobility limitation was adjudicated by a special
Health ABC study committee that considered additionally
available information such as reason for missing study
contact (in nursing home, severe illness) and proxy
information for those participants who died.
Biomedical factors.—Possible biomedical explanatory
variables cover a wide range of clinical and subclinical
diseases. Baseline presence of diseases was determined
using standardized algorithms considering self-report, use of
specific medications, and some clinical assessments.
Baseline prevalent cancer was based on self-reports of
cancer or malignancy and/or use of anticancer medication.
The presence of heart disease was defined as having
coronary heart disease and/or congestive heart failure.
Cerebrovascular disease was defined as a history of stroke
or transient ischemic attack. Peripheral arterial disease was
based on self-reports of intermittent claudication or a history
of lower extremity bypass or angioplasty. Three categories,
using American Diabetes Association criteria, were distin-
guished for glucose intolerance: not impaired (fasting
glucose level ,100 mg/dl), impaired fasting glucose
(fasting glucose level between 100 mg/dl and 126 mg/dl),
and diabetes mellitus (fasting glucose level .126 mg/dl).
Hypercholesterolemic persons had high total cholesterol
levels (240 mg/dl) and/or high low-density lipoprotein
cholesterol levels (130 mg/dl) or were being treated with
lipid-lowering drugs (25). Triglyceride levels were consid-
ered high if .150 mg/dl, and high-density lipoprotein
cholesterol levels were considered low if ,40 mg/dl in men
and ,50 mg/dl in women (26). For hypertension, four
categories were created: normotensive (systolic pressure
,140 mmHg and diastolic pressure ,90 mmHg); normo-
tensive and treated with blood pressure-lowering drugs;
hypertension stage 1 (systolic pressure 140 mmHg or
diastolic pressure 90 mmHg); and hypertension stage 2
(systolic pressure 160 mmHg or diastolic pressure 100
mmHg) (27). Two variables for pulmonary function were
used: a poor forced expiratory volume in 1 second/forced
vital capacity ratio (FEV1/FVC) of 70% or lower, and
percentage predicted FEV1 of 80% or lower (28,29).
Body mass index (BMI) was categorized as lower than
25 kg/m2, between 25 and 30 kg/m2, and higher than 30 kg/
m2. Knee pain was considered if reported to be present at
least 1 month of the past year. Ankle arm blood pressure
index was considered indicative of peripheral arterial
disease if lower than 0.9 (30). Finally, serum level of three
inflammatory markers were assessed: interleukin-6 (IL-6),
C-reactive protein (CRP), and tumor necrosis factor-a
(TNF-a) (20). Each biomarker variable was dichotomized,
where inflammation was defined as being in the highest
tertile of IL-6 (2.40 pg/ml), CRP (2.55 mg/L), and TNF-
a (3.72 pg/ml). In addition, an inflammation index was
calculated as the number of inflammatory markers in the
highest tertile, which has been shown to be an important
predictor of incident mobility limitation (20).
Sociodemographics.—Sociodemographics included age,
sex, race (black, white), study site (Memphis, Pittsburgh),
and marital status (never married, previously married,
married). For the analyses with family income we also
controlled for whether (yes/no) people had household
members other than their spouse.
Statistical Analyses
Analyses were performed using SPSS (version 11.5;
SPSS Inc., Chicago, IL). To determine if there were
differences in the incidence of mobility limitation between
SES groups, unadjusted Cox proportional hazard regression
models were fitted. To determine if there were differences in
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prevalences of the biomedical variables between SES
groups, the chi-square test was used. To evaluate the
association of biomedical factors with time to incident
persistent mobility limitation, Cox proportional hazard
regression models were fitted, adjusting for sociodemo-
graphics. Cox proportional hazard regression models were
also fitted to study the association of SES on time to incident
mobility limitation. Persons surviving with no evidence of
incident limitation were censored at the last study visit,
those dying with no evidence of incident limitation were
censored at time of death, and those lost to follow-up were
censored at their last interview. Two models were fitted; the
first model was adjusted for sociodemographics. The second
model contained all variables of the first model as well as
the biomedical variables. To determine the role of bio-
medical factors, a percentage reduction in hazard ratio (HR)
from model 1 was computed: (HRmodel 1  HRmodel 2)/
(HRmodel 1  1).
RESULTS
Figure 1 shows the incidence rate per 1000 person-years
of incident mobility limitation according to SES. A p value
for trend was statistically significant (p , .001) for all three
SES indicators. More people with low SES had incident
mobility limitation than did those with high SES. Results
are shown for black and white persons together because
interaction terms between any of the SES indicators and race
were not statistically significant (all p . .10).
In further analyses we used only those biomedical
variables that were statistically significant predictors of
incident persistent mobility limitation; because of their
nonsignificance; baseline presence of cancer and hypercho-
lesterolemia were not further considered. All other bio-
medical factors were significant predictors of incident
mobility limitation, adjusted for sociodemographics (not
tabulated). Especially strong predictors were having three
inflammatory markers in the highest tertile (HR: 3.21, 95%
confidence interval [CI]: 2.65, 3.89), peripheral arterial
disease (HR: 2.42, 95% CI: 1.97, 2.96), and knee pain (HR:
2.20, 95% CI: 1.93, 2.50).
Generally, the prevalence of disease and biological risk
factors was higher in low SES groups except for high
triglyceride levels and low high-density lipoprotein choles-
terol levels, for which the prevalence was higher in high
SES groups. Glucose intolerance, hypertension, low pre-
dicted FEV1, high BMI, low ankle arm blood pressure
index, high serum levels of IL-6 and CRP, and having three
inflammatory markers in the highest tertile were statistically
significantly associated with low education, low income,
and few assets (Table 1).
HRs of incident mobility limitation, adjusted for socio-
demographics, were significantly higher in low SES groups
compared to the highest SES group (Table 2, model 1). Low
income showed a particularly increased risk: HRs were 2.80
(95% CI: 2.06, 3.81) in the income group less than $10,000,
and 1.82 (95% CI: 1.40, 2.36) in the income group $10,000 to
less than $25,000 compared to that of those participants with
an income greater than or equal to $50,000. Strong
associations were found between SES and incident mobility
limitation for all three SES indicators. When all SES
indicators were included in one analytic model, all three
indicators remained significant predictors of incident mobility
limitation. Therefore education, income, and number of assets
all had an independent effect on incident mobility limitation.
Biomedical factors (model 2) could explain a substantial
part of the SES gradient in incident mobility limitation. The
largest reduction in HRs was found for education; 48% for
the group with 12 years of education and 33% for the group
with less than 12 years of education (41% on average).
Biomedical factors decreased the HRs by an average of 17%
for income and 29% for the number of assets. Figure 2
shows the biomedical factors that reduced the HRs for the
lowest SES group versus the highest SES group by more
than 5%, adjusted for sociodemographics. High serum levels
of inflammatory markers and high BMI decreased the HRs
by more than 5% for all three SES indicators.
Figure 1. Incidence rate per 1000 person-years of mobility limitation
according to socioeconomic status. *p value based on unadjusted survival
analyses.
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DISCUSSION
In a well-functioning older population, low SES predicted
an increased incidence of mobility limitation during 4½
years of follow-up. Biomedical factors explained a sub-
stantial part of the SES differentials in mobility limitation
incidence. On average, 41% of the educational differences
in mobility limitation incidence was explained by bio-
medical factors; this was 17% for income and 29% for the
number of assets. However, even after taking into account
a wide range of diseases and biological risk factors, persons
in the lowest SES group still had a significant increased risk
of mobility limitation incidence. HRs still ranged from 1.47
to 2.64 in the lowest SES groups compared to the highest
SES groups. HRs were more modest in the middle SES
groups compared to the highest SES groups. High serum
levels of inflammatory markers, high BMI, and hypertension
were found to be the most important biomedical variables in
reducing the HRs for SES. It is notable that these variables
measured biological characteristics rather than diseases.
These biological risk factors have in common that they are
risk factors for a wide variety of health outcomes and may
represent indicators of disease severity.
Relatively few studies in older people have investigated
the relationship between SES and functional outcomes (31–
33). Studies have found that the relationship between SES
and health outcomes were weaker in people aged 65 or older
compared to younger people. In addition, it has been argued
that disparities in income diminish after retirement. In our
study, the effect of SES on poor functional outcomes in
elderly persons was still quite strong.
Besides biomedical factors there may also be other factors
that explain the association between SES and mobility
limitation. These factors may be related to behavioral or
psychosocial factors. Low SES is related to many adverse
behavioral factors, such as smoking status and excessive
alcohol consumption that in turn are related to poor health
outcomes (3,6,34). In this study, the contribution of
Table 1. Distribution (%) of Biomedical Factors by Education, Income, and Number of Assets
Biomedical Factors (%)
Education Income No. of Assets
,12 y 12 y .12 y
p
Value ,$10,000
$10,000–
,$25,000
$25,000–
,$50,000 $50,000
p
Value None 1–2 3–7
p
Value
Heart disease 18.3 17.0 17.2 .75 16.6 17.8 17.5 18.5 .92 18.0 17.0 17.2 .87
Cerebrovascular disease 7.7 6.7 7.6 .63 8.7 8.7 6.6 5.6 .11 9.0 7.4 6.7 .24
Glucose intolerance
Not impaired 59.9 65.0 67.4 ,.001 59.0 63.0 65.1 68.8 .02 62.1 62.6 67.6 ,.001
Impaired fasting glucose 22.4 21.6 21.0 21.6 23.1 21.9 19.3 18.6 21.9 22.4
Diabetic 17.8 13.4 11.5 19.4 13.9 13.0 11.9 19.4 15.6 10.0
Triglycerides .150 mg/dl 23.9 34.3 31.6 ,.001 24.8 30.4 33.8 32.8 .01 25.2 28.0 35.0 ,.001
HDL cholesterol
,40 mg/dl in men,
,50 mg/dl in women 26.7 31.0 29.7 .13 24.9 28.9 32.7 27.7 .07 28.7 27.4 31.6 .06
Hypertension
Normotensive 28.1 28.0 34.9 .001 24.2 26.4 34.4 39.0 ,.001 25.6 28.3 35.4 ,.001
Normotensive with
medications 29.2 31.7 29.8 32.2 32.0 28.7 29.3 33.5 29.9 29.5
Stage 1 27.9 26.6 24.5 26.4 27.8 24.7 23.1 26.0 28.5 23.8
Stage 2 14.8 13.7 10.8 17.1 13.8 12.3 8.5 15.0 13.2 11.3
FEV1/FVC ,70% 24.0 21.2 20.4 .18 24.3 22.7 21.5 18.3 .19 20.1 23.4 20.3 .14
Predicted FEV1 ,80% 28.7 22.3 22.7 .004 28.6 24.5 24.6 19.5 .04 23.8 26.8 21.6 .01
Body mass index
,25 kg/m2 28.0 29.6 36.9 ,.001 29.8 30.1 34.5 35.8 ,.001 27.0 31.1 35.3 ,.001
25–30 kg/m2 40.0 42.6 43.5 35.3 41.2 44.9 46.4 36.0 41.2 45.8
.30 kg/m2 32.0 27.8 19.6 35.0 28.7 20.6 17.8 37.0 27.7 19.0
Peripheral arterial disease 6.4 4.7 5.1 .30 6.1 5.4 5.2 4.0 .60 6.6 5.5 4.7 .25
Ankle arm blood pressure
index ,0.9 19.4 16.4 10.9 ,.001 20.7 16.2 11.9 7.5 ,.001 20.6 17.5 9.0 ,.001
Knee pain 18.7 17.5 14.2 .01 20.4 17.9 14.6 14.5 .03 16.9 17.0 15.6 .60
Highest tertile IL-6 37.5 34.5 29.5 ,.001 40.5 34.7 32.0 26.5 ,.001 38.7 36.4 27.9 ,.001
Highest tertile CRP 38.7 34.8 28.6 ,.001 43.8 36.6 27.1 28.2 ,.001 39.4 36.7 27.6 ,.001
Highest tertile TNF-a 33.5 35.6 31.4 .12 31.8 35.3 34.2 31.3 .42 30.8 34.5 33.2 .35
Inflammation index*
None high 36.6 34.9 43.9 ,.001 33.1 35.2 41.1 45.9 ,.001 36.1 34.7 44.3 ,.001
1 of 3 high 30.2 36.7 31.6 31.6 35.3 33.5 31.2 30.1 35.0 32.2
2 of 3 high 24.1 20.3 18.7 26.3 21.2 19.4 17.2 26.3 21.8 17.2
All 3 high 9.2 8.0 5.8 9.0 8.4 6.0 5.6 7.6 8.5 6.4
Note: HDL¼ high density lipoprotein; FEV1¼ forced expiratory volume in 1 second; FVC¼ forced vital capacity; IL-6¼ interleukin-6; CRP¼C-reactive protein;
TNF-a¼ tumor necrosis factor-a.
*The number of inflammatory marker levels (IL-6, CRP, TNF-a) within the highest tertile.
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biomedical factors in explaining SES difference in incident
mobility limitation is similar when we adjust for smoking
status (current, former, never smoker), alcohol use during the
past year (0, ,1, 1–7, .7 drinks per week), and physical
activity (total kilocalories per kilogram per week) in both
models (data not shown). There is also evidence that
psychosocial factors, such as control beliefs and stress, play
an important role in functional outcomes (35), and also in the
association between SES and poor functional outcomes (36).
This study has some limitations. First, information on
mobility limitation was based on self-report. Second, only
limited information was available on the severity of baseline
diseases. It must be acknowledged that the approach
followed is limited by both the comprehensiveness of the
panel of biomedical factors considered and the reliability
with which these factors have been assessed. We cannot
exclude the possibility that, had the underlying biomedical
factors been measured more exactly, the diminution in the
strength of the SES effect may have been larger. Third, only
baseline data on biomedical factors were analyzed, so the
association between SES on the one hand and biomedical
factors on the other hand might have resulted from reverse
causation; therefore, biomedical factors could have partly
confounded the link between SES and mobility limitation
(37–39). If present, it is likely that this selection effect
would have had a larger effect on income and assets than on
education, as the latter indicator is less sensitive to change
during adulthood. However, in this study, the same results
were found across all SES indicators (including education)
so reversed causation is not very likely.
Our study also has several strengths. First, the study
consists of a large cohort of older black and white adults in
which loss to follow-up for our outcome was very limited
(,4%). Second, because of the longitudinal character of our
study we establish that SES precedes the development of
mobility limitation. Third, we had information on a wide
variety of diseases and biological risk factors that allowed
for a more comprehensive assessment than has been pos-
sible previously. Fourth, all participants were well-func-
tioning at baseline, so the study was designed to determine
incident functional limitation. Mobility limitation is the
most important outcome in the Health ABC study because
of the need to identify risk factors at a stage of age-related
decline that would be amenable to preventive interventions.
Table 2. Hazard Ratios (HR) and 95% Confidence Interval (CI) of
Incident Mobility Limitation by Education, Income,
and Number of Assets
Socioeconomic Status
Model 1* Model 2y
HR 95% CI HR 95% CI % Red.z
Education
.12 y 1.00 1.00
12 y 1.33 1.13, 1.56 1.17 1.00, 1.38 48
,12 y 1.70 1.42, 2.04 1.47 1.23, 1.77 33
Income
$50,000 1.00 1.00
$25,000–,$50,000 1.39 1.07, 1.80 1.33 1.02, 1.73 15
$10,000–,$25,000 1.82 1.40, 2.36 1.61 1.24, 2.09 26
,$10,000 2.80 2.06, 3.81 2.64 1.93, 3.61 9
Missing 1.55 1.15, 2.09 1.45 1.07, 1.96 18
No. of assets
3–7 1.00 1.00
1–2 1.28 1.08, 1.51 1.20 1.02, 1.42 29
None 1.66 1.35, 2.04 1.47 1.19, 1.81 29
*Model 1: adjusted for age, sex, race, study site, other household members
for income, and marital status.
yModel 2: adjusted for age, sex, race, study site, other household members
for income, marital status, and biomedical factors.
zPercentage reduction in hazard ratio from model 1 computed by (HRmodel 1
HRmodel 2)/(HRmodel 1  1).
Figure 2. Biomedical factors that reduced the hazard ratio for the lowest
versus the highest socioeconomic status group by more than 5%, adjusted for
age, sex, race, study site, and marital status.
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Summary
There is a strong association between low SES and
incident mobility limitation in older persons. Part of this
association could be explained by biomedical factors. This
study suggests that biomedical factors are important in the
mechanism underlying the association between SES and
poor functional outcomes. However, to reduce physical
disabilities and, in particular, the SES differences therein, it
may not be sufficient to solely intervene on biological risk
factors and risks of diseases.
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